Active Pharmaceutical Ingredients-Global Market Status and Trend Report 2013-2023
Report Summary
Active Pharmaceutical Ingredients-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Active Pharmaceutical Ingredients industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Active Pharmaceutical Ingredients 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Active Pharmaceutical Ingredients worldwide, with company and product introduction, position in the Active Pharmaceutical Ingredients market
Market status and development trend of Active Pharmaceutical Ingredients by types and applications
Cost and profit status of Active Pharmaceutical Ingredients, and marketing status
Market growth drivers and challenges
The report segments the global Active Pharmaceutical Ingredients market as:
Global Active Pharmaceutical Ingredients Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Active Pharmaceutical Ingredients Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Synthetic APIs
Biotech APIs
Global Active Pharmaceutical Ingredients Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others
Global Active Pharmaceutical Ingredients Market: Manufacturers Segment Analysis (Company and Product introduction, Active Pharmaceutical Ingredients Sales Volume, Revenue, Price and Gross Margin):
Teva
Mylan
DSM
Aurobindo Pharma
Aspen
Novartis
BASF
Pfizer
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddy's Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Active Pharmaceutical Ingredients-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Active Pharmaceutical Ingredients industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Active Pharmaceutical Ingredients 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Active Pharmaceutical Ingredients worldwide, with company and product introduction, position in the Active Pharmaceutical Ingredients market
Market status and development trend of Active Pharmaceutical Ingredients by types and applications
Cost and profit status of Active Pharmaceutical Ingredients, and marketing status
Market growth drivers and challenges
The report segments the global Active Pharmaceutical Ingredients market as:
Global Active Pharmaceutical Ingredients Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Active Pharmaceutical Ingredients Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Synthetic APIs
Biotech APIs
Global Active Pharmaceutical Ingredients Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others
Global Active Pharmaceutical Ingredients Market: Manufacturers Segment Analysis (Company and Product introduction, Active Pharmaceutical Ingredients Sales Volume, Revenue, Price and Gross Margin):
Teva
Mylan
DSM
Aurobindo Pharma
Aspen
Novartis
BASF
Pfizer
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddy's Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF ACTIVE PHARMACEUTICAL INGREDIENTS
1.1 Definition of Active Pharmaceutical Ingredients in This Report
1.2 Commercial Types of Active Pharmaceutical Ingredients
1.2.1 Synthetic APIs
1.2.2 Biotech APIs
1.3 Downstream Application of Active Pharmaceutical Ingredients
1.3.1 CNS
1.3.2 Cardiovascular
1.3.3 Genitourinary/Hormonal Drugs
1.3.4 Respiratory
1.3.5 Rheumatology
1.3.6 Diabetes
1.3.7 Oncology
1.3.8 Others
1.4 Development History of Active Pharmaceutical Ingredients
1.5 Market Status and Trend of Active Pharmaceutical Ingredients 2013-2023
1.5.1 Global Active Pharmaceutical Ingredients Market Status and Trend 2013-2023
1.5.2 Regional Active Pharmaceutical Ingredients Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Active Pharmaceutical Ingredients 2013-2017
2.2 Sales Market of Active Pharmaceutical Ingredients by Regions
2.2.1 Sales Volume of Active Pharmaceutical Ingredients by Regions
2.2.2 Sales Value of Active Pharmaceutical Ingredients by Regions
2.3 Production Market of Active Pharmaceutical Ingredients by Regions
2.4 Global Market Forecast of Active Pharmaceutical Ingredients 2018-2023
2.4.1 Global Market Forecast of Active Pharmaceutical Ingredients 2018-2023
2.4.2 Market Forecast of Active Pharmaceutical Ingredients by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Active Pharmaceutical Ingredients by Types
3.2 Sales Value of Active Pharmaceutical Ingredients by Types
3.3 Market Forecast of Active Pharmaceutical Ingredients by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Active Pharmaceutical Ingredients by Downstream Industry
4.2 Global Market Forecast of Active Pharmaceutical Ingredients by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Active Pharmaceutical Ingredients Market Status by Countries
5.1.1 North America Active Pharmaceutical Ingredients Sales by Countries (2013-2017)
5.1.2 North America Active Pharmaceutical Ingredients Revenue by Countries (2013-2017)
5.1.3 United States Active Pharmaceutical Ingredients Market Status (2013-2017)
5.1.4 Canada Active Pharmaceutical Ingredients Market Status (2013-2017)
5.1.5 Mexico Active Pharmaceutical Ingredients Market Status (2013-2017)
5.2 North America Active Pharmaceutical Ingredients Market Status by Manufacturers
5.3 North America Active Pharmaceutical Ingredients Market Status by Type (2013-2017)
5.3.1 North America Active Pharmaceutical Ingredients Sales by Type (2013-2017)
5.3.2 North America Active Pharmaceutical Ingredients Revenue by Type (2013-2017)
5.4 North America Active Pharmaceutical Ingredients Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Active Pharmaceutical Ingredients Market Status by Countries
6.1.1 Europe Active Pharmaceutical Ingredients Sales by Countries (2013-2017)
6.1.2 Europe Active Pharmaceutical Ingredients Revenue by Countries (2013-2017)
6.1.3 Germany Active Pharmaceutical Ingredients Market Status (2013-2017)
6.1.4 UK Active Pharmaceutical Ingredients Market Status (2013-2017)
6.1.5 France Active Pharmaceutical Ingredients Market Status (2013-2017)
6.1.6 Italy Active Pharmaceutical Ingredients Market Status (2013-2017)
6.1.7 Russia Active Pharmaceutical Ingredients Market Status (2013-2017)
6.1.8 Spain Active Pharmaceutical Ingredients Market Status (2013-2017)
6.1.9 Benelux Active Pharmaceutical Ingredients Market Status (2013-2017)
6.2 Europe Active Pharmaceutical Ingredients Market Status by Manufacturers
6.3 Europe Active Pharmaceutical Ingredients Market Status by Type (2013-2017)
6.3.1 Europe Active Pharmaceutical Ingredients Sales by Type (2013-2017)
6.3.2 Europe Active Pharmaceutical Ingredients Revenue by Type (2013-2017)
6.4 Europe Active Pharmaceutical Ingredients Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Active Pharmaceutical Ingredients Market Status by Countries
7.1.1 Asia Pacific Active Pharmaceutical Ingredients Sales by Countries (2013-2017)
7.1.2 Asia Pacific Active Pharmaceutical Ingredients Revenue by Countries (2013-2017)
7.1.3 China Active Pharmaceutical Ingredients Market Status (2013-2017)
7.1.4 Japan Active Pharmaceutical Ingredients Market Status (2013-2017)
7.1.5 India Active Pharmaceutical Ingredients Market Status (2013-2017)
7.1.6 Southeast Asia Active Pharmaceutical Ingredients Market Status (2013-2017)
7.1.7 Australia Active Pharmaceutical Ingredients Market Status (2013-2017)
7.2 Asia Pacific Active Pharmaceutical Ingredients Market Status by Manufacturers
7.3 Asia Pacific Active Pharmaceutical Ingredients Market Status by Type (2013-2017)
7.3.1 Asia Pacific Active Pharmaceutical Ingredients Sales by Type (2013-2017)
7.3.2 Asia Pacific Active Pharmaceutical Ingredients Revenue by Type (2013-2017)
7.4 Asia Pacific Active Pharmaceutical Ingredients Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Active Pharmaceutical Ingredients Market Status by Countries
8.1.1 Latin America Active Pharmaceutical Ingredients Sales by Countries (2013-2017)
8.1.2 Latin America Active Pharmaceutical Ingredients Revenue by Countries (2013-2017)
8.1.3 Brazil Active Pharmaceutical Ingredients Market Status (2013-2017)
8.1.4 Argentina Active Pharmaceutical Ingredients Market Status (2013-2017)
8.1.5 Colombia Active Pharmaceutical Ingredients Market Status (2013-2017)
8.2 Latin America Active Pharmaceutical Ingredients Market Status by Manufacturers
8.3 Latin America Active Pharmaceutical Ingredients Market Status by Type (2013-2017)
8.3.1 Latin America Active Pharmaceutical Ingredients Sales by Type (2013-2017)
8.3.2 Latin America Active Pharmaceutical Ingredients Revenue by Type (2013-2017)
8.4 Latin America Active Pharmaceutical Ingredients Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Active Pharmaceutical Ingredients Market Status by Countries
9.1.1 Middle East and Africa Active Pharmaceutical Ingredients Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Active Pharmaceutical Ingredients Revenue by Countries (2013-2017)
9.1.3 Middle East Active Pharmaceutical Ingredients Market Status (2013-2017)
9.1.4 Africa Active Pharmaceutical Ingredients Market Status (2013-2017)
9.2 Middle East and Africa Active Pharmaceutical Ingredients Market Status by Manufacturers
9.3 Middle East and Africa Active Pharmaceutical Ingredients Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Active Pharmaceutical Ingredients Sales by Type (2013-2017)
9.3.2 Middle East and Africa Active Pharmaceutical Ingredients Revenue by Type (2013-2017)
9.4 Middle East and Africa Active Pharmaceutical Ingredients Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF ACTIVE PHARMACEUTICAL INGREDIENTS
10.1 Global Economy Situation and Trend Overview
10.2 Active Pharmaceutical Ingredients Downstream Industry Situation and Trend Overview
CHAPTER 11 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Active Pharmaceutical Ingredients by Major Manufacturers
11.2 Production Value of Active Pharmaceutical Ingredients by Major Manufacturers
11.3 Basic Information of Active Pharmaceutical Ingredients by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Active Pharmaceutical Ingredients Major Manufacturer
11.3.2 Employees and Revenue Level of Active Pharmaceutical Ingredients Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 ACTIVE PHARMACEUTICAL INGREDIENTS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Teva
12.1.1 Company profile
12.1.2 Representative Active Pharmaceutical Ingredients Product
12.1.3 Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin of Teva
12.2 Mylan
12.2.1 Company profile
12.2.2 Representative Active Pharmaceutical Ingredients Product
12.2.3 Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin of Mylan
12.3 DSM
12.3.1 Company profile
12.3.2 Representative Active Pharmaceutical Ingredients Product
12.3.3 Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin of DSM
12.4 Aurobindo Pharma
12.4.1 Company profile
12.4.2 Representative Active Pharmaceutical Ingredients Product
12.4.3 Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin of Aurobindo Pharma
12.5 Aspen
12.5.1 Company profile
12.5.2 Representative Active Pharmaceutical Ingredients Product
12.5.3 Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin of Aspen
12.6 Novartis
12.6.1 Company profile
12.6.2 Representative Active Pharmaceutical Ingredients Product
12.6.3 Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin of Novartis
12.7 BASF
12.7.1 Company profile
12.7.2 Representative Active Pharmaceutical Ingredients Product
12.7.3 Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin of BASF
12.8 Pfizer
12.8.1 Company profile
12.8.2 Representative Active Pharmaceutical Ingredients Product
12.8.3 Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin of Pfizer
12.9 Huahai Pharmaceutical
12.9.1 Company profile
12.9.2 Representative Active Pharmaceutical Ingredients Product
12.9.3 Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin of Huahai Pharmaceutical
12.10 Hisun Pharmaceutical
12.10.1 Company profile
12.10.2 Representative Active Pharmaceutical Ingredients Product
12.10.3 Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin of Hisun Pharmaceutical
12.11 Sun Pharmaceutical Industries
12.11.1 Company profile
12.11.2 Representative Active Pharmaceutical Ingredients Product
12.11.3 Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin of Sun Pharmaceutical Industries
12.12 Zhejiang Medicine
12.12.1 Company profile
12.12.2 Representative Active Pharmaceutical Ingredients Product
12.12.3 Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin of Zhejiang Medicine
12.13 Dr. Reddy's Laboratories
12.13.1 Company profile
12.13.2 Representative Active Pharmaceutical Ingredients Product
12.13.3 Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin of Dr. Reddy's Laboratories
12.14 Zhejiang NHU
12.14.1 Company profile
12.14.2 Representative Active Pharmaceutical Ingredients Product
12.14.3 Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin of Zhejiang NHU
12.15 Bayer
12.15.1 Company profile
12.15.2 Representative Active Pharmaceutical Ingredients Product
12.15.3 Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin of Bayer
12.16 NCPC
12.17 AbbVie
12.18 Shandong Xinhua Pharmaceutical
12.19 Northeast Pharm
12.20 Harbin Pharmaceutical
12.21 LKPC
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ACTIVE PHARMACEUTICAL INGREDIENTS
13.1 Industry Chain of Active Pharmaceutical Ingredients
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF ACTIVE PHARMACEUTICAL INGREDIENTS
14.1 Cost Structure Analysis of Active Pharmaceutical Ingredients
14.2 Raw Materials Cost Analysis of Active Pharmaceutical Ingredients
14.3 Labor Cost Analysis of Active Pharmaceutical Ingredients
14.4 Manufacturing Expenses Analysis of Active Pharmaceutical Ingredients
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Active Pharmaceutical Ingredients in This Report
1.2 Commercial Types of Active Pharmaceutical Ingredients
1.2.1 Synthetic APIs
1.2.2 Biotech APIs
1.3 Downstream Application of Active Pharmaceutical Ingredients
1.3.1 CNS
1.3.2 Cardiovascular
1.3.3 Genitourinary/Hormonal Drugs
1.3.4 Respiratory
1.3.5 Rheumatology
1.3.6 Diabetes
1.3.7 Oncology
1.3.8 Others
1.4 Development History of Active Pharmaceutical Ingredients
1.5 Market Status and Trend of Active Pharmaceutical Ingredients 2013-2023
1.5.1 Global Active Pharmaceutical Ingredients Market Status and Trend 2013-2023
1.5.2 Regional Active Pharmaceutical Ingredients Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Active Pharmaceutical Ingredients 2013-2017
2.2 Sales Market of Active Pharmaceutical Ingredients by Regions
2.2.1 Sales Volume of Active Pharmaceutical Ingredients by Regions
2.2.2 Sales Value of Active Pharmaceutical Ingredients by Regions
2.3 Production Market of Active Pharmaceutical Ingredients by Regions
2.4 Global Market Forecast of Active Pharmaceutical Ingredients 2018-2023
2.4.1 Global Market Forecast of Active Pharmaceutical Ingredients 2018-2023
2.4.2 Market Forecast of Active Pharmaceutical Ingredients by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Active Pharmaceutical Ingredients by Types
3.2 Sales Value of Active Pharmaceutical Ingredients by Types
3.3 Market Forecast of Active Pharmaceutical Ingredients by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Active Pharmaceutical Ingredients by Downstream Industry
4.2 Global Market Forecast of Active Pharmaceutical Ingredients by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Active Pharmaceutical Ingredients Market Status by Countries
5.1.1 North America Active Pharmaceutical Ingredients Sales by Countries (2013-2017)
5.1.2 North America Active Pharmaceutical Ingredients Revenue by Countries (2013-2017)
5.1.3 United States Active Pharmaceutical Ingredients Market Status (2013-2017)
5.1.4 Canada Active Pharmaceutical Ingredients Market Status (2013-2017)
5.1.5 Mexico Active Pharmaceutical Ingredients Market Status (2013-2017)
5.2 North America Active Pharmaceutical Ingredients Market Status by Manufacturers
5.3 North America Active Pharmaceutical Ingredients Market Status by Type (2013-2017)
5.3.1 North America Active Pharmaceutical Ingredients Sales by Type (2013-2017)
5.3.2 North America Active Pharmaceutical Ingredients Revenue by Type (2013-2017)
5.4 North America Active Pharmaceutical Ingredients Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Active Pharmaceutical Ingredients Market Status by Countries
6.1.1 Europe Active Pharmaceutical Ingredients Sales by Countries (2013-2017)
6.1.2 Europe Active Pharmaceutical Ingredients Revenue by Countries (2013-2017)
6.1.3 Germany Active Pharmaceutical Ingredients Market Status (2013-2017)
6.1.4 UK Active Pharmaceutical Ingredients Market Status (2013-2017)
6.1.5 France Active Pharmaceutical Ingredients Market Status (2013-2017)
6.1.6 Italy Active Pharmaceutical Ingredients Market Status (2013-2017)
6.1.7 Russia Active Pharmaceutical Ingredients Market Status (2013-2017)
6.1.8 Spain Active Pharmaceutical Ingredients Market Status (2013-2017)
6.1.9 Benelux Active Pharmaceutical Ingredients Market Status (2013-2017)
6.2 Europe Active Pharmaceutical Ingredients Market Status by Manufacturers
6.3 Europe Active Pharmaceutical Ingredients Market Status by Type (2013-2017)
6.3.1 Europe Active Pharmaceutical Ingredients Sales by Type (2013-2017)
6.3.2 Europe Active Pharmaceutical Ingredients Revenue by Type (2013-2017)
6.4 Europe Active Pharmaceutical Ingredients Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Active Pharmaceutical Ingredients Market Status by Countries
7.1.1 Asia Pacific Active Pharmaceutical Ingredients Sales by Countries (2013-2017)
7.1.2 Asia Pacific Active Pharmaceutical Ingredients Revenue by Countries (2013-2017)
7.1.3 China Active Pharmaceutical Ingredients Market Status (2013-2017)
7.1.4 Japan Active Pharmaceutical Ingredients Market Status (2013-2017)
7.1.5 India Active Pharmaceutical Ingredients Market Status (2013-2017)
7.1.6 Southeast Asia Active Pharmaceutical Ingredients Market Status (2013-2017)
7.1.7 Australia Active Pharmaceutical Ingredients Market Status (2013-2017)
7.2 Asia Pacific Active Pharmaceutical Ingredients Market Status by Manufacturers
7.3 Asia Pacific Active Pharmaceutical Ingredients Market Status by Type (2013-2017)
7.3.1 Asia Pacific Active Pharmaceutical Ingredients Sales by Type (2013-2017)
7.3.2 Asia Pacific Active Pharmaceutical Ingredients Revenue by Type (2013-2017)
7.4 Asia Pacific Active Pharmaceutical Ingredients Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Active Pharmaceutical Ingredients Market Status by Countries
8.1.1 Latin America Active Pharmaceutical Ingredients Sales by Countries (2013-2017)
8.1.2 Latin America Active Pharmaceutical Ingredients Revenue by Countries (2013-2017)
8.1.3 Brazil Active Pharmaceutical Ingredients Market Status (2013-2017)
8.1.4 Argentina Active Pharmaceutical Ingredients Market Status (2013-2017)
8.1.5 Colombia Active Pharmaceutical Ingredients Market Status (2013-2017)
8.2 Latin America Active Pharmaceutical Ingredients Market Status by Manufacturers
8.3 Latin America Active Pharmaceutical Ingredients Market Status by Type (2013-2017)
8.3.1 Latin America Active Pharmaceutical Ingredients Sales by Type (2013-2017)
8.3.2 Latin America Active Pharmaceutical Ingredients Revenue by Type (2013-2017)
8.4 Latin America Active Pharmaceutical Ingredients Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Active Pharmaceutical Ingredients Market Status by Countries
9.1.1 Middle East and Africa Active Pharmaceutical Ingredients Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Active Pharmaceutical Ingredients Revenue by Countries (2013-2017)
9.1.3 Middle East Active Pharmaceutical Ingredients Market Status (2013-2017)
9.1.4 Africa Active Pharmaceutical Ingredients Market Status (2013-2017)
9.2 Middle East and Africa Active Pharmaceutical Ingredients Market Status by Manufacturers
9.3 Middle East and Africa Active Pharmaceutical Ingredients Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Active Pharmaceutical Ingredients Sales by Type (2013-2017)
9.3.2 Middle East and Africa Active Pharmaceutical Ingredients Revenue by Type (2013-2017)
9.4 Middle East and Africa Active Pharmaceutical Ingredients Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF ACTIVE PHARMACEUTICAL INGREDIENTS
10.1 Global Economy Situation and Trend Overview
10.2 Active Pharmaceutical Ingredients Downstream Industry Situation and Trend Overview
CHAPTER 11 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Active Pharmaceutical Ingredients by Major Manufacturers
11.2 Production Value of Active Pharmaceutical Ingredients by Major Manufacturers
11.3 Basic Information of Active Pharmaceutical Ingredients by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Active Pharmaceutical Ingredients Major Manufacturer
11.3.2 Employees and Revenue Level of Active Pharmaceutical Ingredients Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 ACTIVE PHARMACEUTICAL INGREDIENTS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Teva
12.1.1 Company profile
12.1.2 Representative Active Pharmaceutical Ingredients Product
12.1.3 Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin of Teva
12.2 Mylan
12.2.1 Company profile
12.2.2 Representative Active Pharmaceutical Ingredients Product
12.2.3 Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin of Mylan
12.3 DSM
12.3.1 Company profile
12.3.2 Representative Active Pharmaceutical Ingredients Product
12.3.3 Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin of DSM
12.4 Aurobindo Pharma
12.4.1 Company profile
12.4.2 Representative Active Pharmaceutical Ingredients Product
12.4.3 Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin of Aurobindo Pharma
12.5 Aspen
12.5.1 Company profile
12.5.2 Representative Active Pharmaceutical Ingredients Product
12.5.3 Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin of Aspen
12.6 Novartis
12.6.1 Company profile
12.6.2 Representative Active Pharmaceutical Ingredients Product
12.6.3 Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin of Novartis
12.7 BASF
12.7.1 Company profile
12.7.2 Representative Active Pharmaceutical Ingredients Product
12.7.3 Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin of BASF
12.8 Pfizer
12.8.1 Company profile
12.8.2 Representative Active Pharmaceutical Ingredients Product
12.8.3 Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin of Pfizer
12.9 Huahai Pharmaceutical
12.9.1 Company profile
12.9.2 Representative Active Pharmaceutical Ingredients Product
12.9.3 Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin of Huahai Pharmaceutical
12.10 Hisun Pharmaceutical
12.10.1 Company profile
12.10.2 Representative Active Pharmaceutical Ingredients Product
12.10.3 Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin of Hisun Pharmaceutical
12.11 Sun Pharmaceutical Industries
12.11.1 Company profile
12.11.2 Representative Active Pharmaceutical Ingredients Product
12.11.3 Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin of Sun Pharmaceutical Industries
12.12 Zhejiang Medicine
12.12.1 Company profile
12.12.2 Representative Active Pharmaceutical Ingredients Product
12.12.3 Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin of Zhejiang Medicine
12.13 Dr. Reddy's Laboratories
12.13.1 Company profile
12.13.2 Representative Active Pharmaceutical Ingredients Product
12.13.3 Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin of Dr. Reddy's Laboratories
12.14 Zhejiang NHU
12.14.1 Company profile
12.14.2 Representative Active Pharmaceutical Ingredients Product
12.14.3 Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin of Zhejiang NHU
12.15 Bayer
12.15.1 Company profile
12.15.2 Representative Active Pharmaceutical Ingredients Product
12.15.3 Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin of Bayer
12.16 NCPC
12.17 AbbVie
12.18 Shandong Xinhua Pharmaceutical
12.19 Northeast Pharm
12.20 Harbin Pharmaceutical
12.21 LKPC
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ACTIVE PHARMACEUTICAL INGREDIENTS
13.1 Industry Chain of Active Pharmaceutical Ingredients
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF ACTIVE PHARMACEUTICAL INGREDIENTS
14.1 Cost Structure Analysis of Active Pharmaceutical Ingredients
14.2 Raw Materials Cost Analysis of Active Pharmaceutical Ingredients
14.3 Labor Cost Analysis of Active Pharmaceutical Ingredients
14.4 Manufacturing Expenses Analysis of Active Pharmaceutical Ingredients
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
